The Accreditation Council for CME (ACCME) is reorganizing one of its departments to provide better monitoring of certified activities and to expand education to members.

Bruce Bellande, PhD, was pleased to learn this month that regulators accepted the cache of materials he sent them as adequate demonstration of corporate separation.

Non-accredited commercial providers have nearly two years to comply with new medical education rules affecting their ability to jointly sponsor activities, regulators said yesterday.

New hires in Pfizer's medical education grants (MEG) department signal the firm is moving in a new direction while raising competencies.

Good, old-fashioned continuing medical education (CME)—the kind produced by accredited providers—has lost its cachet. Once the medical-education flagship, it has been subsumed in a sea of other types of activities: online and off-, self-directed and live, promotional and non-biased. The result is that "CME" has become a catchall to denote all manner of med ed.

Pfizer has signed on as the first pharmaceutical client of Sermo, the online community for physicians.

A new policy that has profound effects on how medical education outfits do business has put some previously understood issues in play for industry.

A task force convened by New Jersey Attorney General Anne Milgram was scheduled to meet yesterday to explore the issue of pharma gift-giving to physicians.

Pfizer, in the midst of revamping its CME department, scored a coup with the recent hiring of Maureen Doyle-Scharff, MBA.

In a medical-education ruling expected to have broad consequences, regulators said they will consider advertising agencies and journal publishers as commercial entities, requiring those that own CME units to spin them off as separate companies, and providing an extra layer of independence to firewalls that may already exist between the two.